Performance improvement of the LM device and its application to precise measurement of motion trajectories within a small range with a machining centre

In order to apply the LM device previously developed to precisely measuring small motion trajectories located on the different motion planes, three major improvements are successfully performed under the condition of completely maintaining the advantages of the device. These improvements include 1) development of a novel connection mechanism to smoothly attach the device to the spindle of a machining centre; 2) employment of a new data sampling method to achieve a high sampling frequency independent of the operating system of the control computer; and 3) proposal of a set-up method to conveniently install the device on the test machining centre with respect to different motion planes. Practical measurement experiment results with the improved device on a machining centre sufficiently demonstrate the effectiveness of the improvements and confirm several features including a very good response to small displacement close to the resolution of the device, high precision, repeatability and reliance. Moreover, based on the measurement results for a number of trajectories for a wide range of motion conditions, the error characteristics of small size motions are systematically discussed and the effect of the movement size and feed rate on the motion accuracy is verified for the machining centre tested

5,6-Dimethyl-1,2,4-triazin-3-amine

In the crystal structure of the title compound, C5H8N4, adjacent mol­ecules are connected through N—H⋯N hydrogen bonds, resulting in a zigzag chain along [100]. The amino groups and heterocyclic N atoms are involved in further N—H⋯N hydrogen bonds, forming R 2 2(8) motifs

trans-4-(1-Naphth­yl)-2-oxo-1,3-oxazolidine-5-carboxylic acid

The crystal structure of the title compound, C14H11NO4, is influenced by N—H⋯O and O—H⋯O hydrogen bonds, linking mol­ecules into one-dimensional tapes running along the [010] direction

MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells.

Pancreatic adenocarcinoma is one of the most leading causes of cancer-related deaths worldwide. Although recent advances provide various treatment options, pancreatic adenocarcinoma has poor prognosis due to its late diagnosis and ineffective therapeutic multimodality. Gemcitabine is the effective first-line drug in pancreatic adenocarcinoma treatment. However, gemcitabine chemoresistance of pancreatic adenocarcinoma cells has been a major obstacle for limiting its treatment effect. Our study found that p70S6K1 plays an important role in gemcitabine chemoresistence. MiR-145 is a tumor suppressor which directly targets p70S6K1 for inhibiting its expression in pancreatic adenocarcinoma, providing new therapeutic scheme. Our findings revealed a new mechanism underlying gemcitabine chemoresistance in pancreatic adenocarcinoma cells

Twist1 enhances hypoxia induced radioresistance in cervical cancer cells by promoting nuclear EGFR localization

Twist1 is a crucial transcription factor that regulates epithelial mesenchymal transition and involves in metastasis. Recent evidence suggests that Twist1 plays important role in hypoxia-induced radioresistance, but the underlying mechanism remains elusive. Here we investigated the change of Twist1 expression in human cervical squamous cancer cell line SiHa after hypoxia treatment. We also explored the role of Twist1 in radioresistance by manipulating the expression level of Twist1.We observed that hypoxia treatment elevated the expression of Twist1 in SiHa cells. Knockdown of Twist1 with siRNA increased the radiosensitivity of SiHa cells under hypoxia condition, accompanied by reduced levels of nuclear Epidermal Growth Factor Receptor (EGFR) and DNA-dependent protein kinase (DNA-PK). Conversely, overexpression of Twist1 led to increased radioresistance of SiHa cells, which in turn increased nuclear EGFR localisation and expression levels of nuclear DNA-PK. Moreover, concomitant high expression of hypoxia-inducible factor-1? (HIF-1?) and Twist1 in primary tumors of cervical cancer patients correlated with the worse prognosis after irradiation treatment. Taken together, these data provide new insights into molecular mechanism underlying hypoxia-induced radio resistance in cervical cancer cells, and suggest that Twist1 is a promising molecular target to improve the efficacy of cancer radiotherapy